Strains of HSV-1 have been noted to vary in their pathogenesis. We compared the replication of strains KOS and McKrae in mice by two routes of infection, ocular and vaginal. Peripheral replication of KOS was similar (cornea) or attenuated over time (vagina) compared with McKrae; however, McKrae replicated in the nervous system to significantly higher levels than KOS after inoculation by either route. Host genetic background strongly influenced the capacity for virus entry into the nervous system from the vagina. KOS and McKrae replicated equivalently after intracranial inoculation, indicating that McKrae's pathogenic phenotype is linked to neuroinvasiveness rather than neurovirulence.
in tissue culture. McKrae undergoes spontaneous or induced reactivation at a higher frequency and is among the most virulent HSV-1 strains in animal models (Hill et al., 1987; Perng et al., 2002; Sawtell et al., 1998; Strelow et al., 1994) .
Inter-strain differences in HSV-1 peripheral replication and virulence have been observed in animal models. HSV-1 strain KOS replicates as well as or better than strain 17syn+ or McKrae in the snout or cornea of mice (Sawtell et al., 1998; Strelow et al., 1994) , although bioluminescence imaging indicates KOS is attenuated relative to 17syn+ and McKrae over time after inoculation in these sites (Luker et al., 2006) . After injection into the footpad or anterior chamber, KOS reaches the nervous system similarly to 17syn+ or H129, respectively, but is dramatically reduced in its capacity to disseminate in neural tissue (Thompson et al., 1986; Archin and Atherton, 2002) and to cause lethal infection after intracranial (i.c.) inoculation compared with other strains (Dix et al., 1983) . HSV-1 strain McKrae, in contrast to KOS, is highly virulent following corneal inoculation of rabbits and mice (Perng et al., 1995) . KOS and McKrae appear to replicate efficiently in the mucosa after intravaginal (i.vag.) inoculation in some studies (Inagaki-Ohara et al., 2000; Zheng et al. 2012) but not others (Murphy et al., 2003) , and neither appears to reach the nervous system (Inagaki-Ohara et al., 2000; Zheng et al., 2012) . However, a direct comparison of these two HSV-1 strains by the genital route has not been reported. In one study comparing i.vag. inoculation of HSV-1 strain 17syn+ to strain IES, a thymidine kinase-deficient mutant (Muller et al., 1979) , 17syn+ replicated for a prolonged period in the genital mucosa, caused severe vaginitis, and spread more readily to the nervous system (Podlech et al., 1996) . Taken together, these observations suggest strain-and route-dependent differences in HSV-1 neuroinvasiveness.
To directly test strain-dependent differences in pathogenesis during acute infection, we compared the capacity of HSV-1 strains KOS and McKrae to replicate and spread in mice after inoculation by two routes relevant to human infection, the cornea and the genital tract. After inoculation of C57BL/6 (B6) mice via the cornea as previously described (Morrison and Knipe, 1994) , KOS and McKrae replicated to a similar extent in the corneal epithelium through 4 d post-infection (Fig. 1A) . Subsequently, KOS replicated to nearly the same extent as McKrae in the trigeminal ganglia; however, KOS titers in the brainstem and brain were reduced 100-fold compared with McKrae (Fig. 1B) . To determine the effect of host genetic background on KOS attenuation, we repeated the experiment in BALB.B mice which share the MHC locus of B6 mice but diverge with regard to non MHC-linked genes. KOS replicated as well as or slightly better than McKrae over time in the corneal epithelium of BALB.B mice (Fig. 1C ), but again was markedly attenuated for replication in the nervous system (Fig. 1D ).
To distinguish whether the persistent neural attenuation of KOS reflects a reduced capacity to spread into the central nervous system (CNS) or to replicate in neural tissue, mice were infected i.c. with strains KOS or McKrae as previously described (Korom et al., 2008) . Replication of KOS and McKrae was equivalent in B6 ( Fig. 2A ) and BALB.B (Fig. 2B ) mice at 24 h post-infection, and both viruses replicated to higher titers in BALB.B mice than B6 mice. To ensure that virus titers had not simply reached their maximum, we also examined titers of the viruses 48 h post-infection. Both strains showed a similar increase in titer at 48 h. These data suggest that the attenuation of KOS after corneal inoculation represents a defect in neuroinvasiveness rather than in growth in neural tissue.
We also infected mice i.vag. as previously described (Morrison et al., 1998) with KOS and McKrae. In B6 mice, KOS and McKrae replicated to similar extents in the vaginal mucosa (Fig. 3A) , except for a transient spike in the day 4 titers of McKrae-infected mice. Only McKrae, however, caused significant inflammation of the external genitalia (Fig. 3B) , and weight loss (data not shown). KOS was not detected in neural tissue and McKrae was detected only in rare instances (Fig. 3C) . In BALB.B mice, KOS and McKrae replicated to nearly the same extent in the vaginal mucosa over the first 2 d post-infection (Fig. 3D) . From 3 to 5 d post-infection, however, the titer of KOS fell to an undetectable level, while replication of McKrae declined more slowly. McKrae also provoked genital inflammation which steadily grew more severe (Fig. 3E) . In contrast, mice infected i.vag. with KOS showed no signs of genital disease. Body weight of McKrae-infected mice also declined an average of 15% by 7 d post-infection, whereas mice infected with KOS gained weight (data not shown). McKrae replicated robustly in spinal cord, brainstem, and brain of BALB.B mice, but KOS was below the level of detection in nearly all cases (Fig. 3F) . Thus, McKrae caused peripheral disease and spread to the CNS of mice after i.vag. inoculation much more readily than KOS.
HSV-1 strains KOS and McKrae are examples of strains with low and high reactivation potential, respectively, in animal models of ocular infection (Berman and Hill, 1985; Gerdes and Smith, 1983; Gordon et al., 1990; Hill et al., 1987; Laycock et al., 1991; Sawtell et al., 1998; Shimeld et al., 1990; Strelow et al., 1994; Willey et al., 1984 ). Here we demonstrate by direct in vivo comparison that HSV-1 strains KOS and McKrae also differ in neuroinvasiveness or capacity to spread into the CNS after ocular or vaginal infection of mice. The differences in replication capacity in vivo were not reproduced in primary mouse fibroblast, brainstem astrocyte, or brainstem neuron cultures (data not shown), suggesting factors in the intact host restrict KOS replication and spread. Importantly, because B6 and BALB.B mice share the same H-2 haplotype, the greater attenuation of KOS compared with McKrae that we observed in B6 mice indicates a non MHC-linked host resistance mechanism.
Replication of McKrae resembled that of KOS in the vaginal mucosa of B6 mice, except for a transient upturn on day 4 post-infection, which is typically observed with virulent strains in the i.vag. model (Thebeau et al., 2007; Morrison 2008; Vagvala et al., 2009 ). This increase may result from virus infection of newly regenerated vaginal epithelial cells, or virus returning from the dorsal root ganglia to the mucosa and amplifying the infection. Further investigation will be needed to distinguish between these possibilities. We made the novel observation that KOS replication is comparatively restricted in the vaginal mucosa of BALB.B mice, primarily after day 2 post-infection. This attenuation may represent differential sensitivity of KOS to type I IFNs (Murphy et al., 2003) or substance P (Svensson et al., 2005) but is more likely related to innate cellular immune responses such as neutrophils or NK T cells (Milligan et al., 2001; Ashkar and Rosenthal, 2003) . Conceivably, HSV-1 strain-dependent differences in chemokine production could elicit different types or amount of inflammatory cell infiltrates in the mouse genital tract (Zheng et al., 2012) . Reduced capacity of KOS to counteract TLR2 or type I IFN signaling in the CNS (KurtJones et al., 2004; Wang et al., 2012) could also possibly play a role in its relative neural attenuation.
Two lines of evidence from our study demonstrate that KOS has a defect in neuroinvasiveness and/or neural spread rather than neurovirulence. First, KOS replicated to a similar extent as McKrae after direct i.c. inoculation, indicating KOS has no inherent defect for growth in the CNS; however, KOS was not detected in the nervous system of most mice after i.vag. inoculation. Second, although KOS and McKrae replicated in the cornea and spread from the cornea to the TG with approximately equal efficiency in B6 mice, McKrae spread from the TG to the CNS more aggressively than KOS. Our results using the corneal and vaginal routes of infection, combined with previous results of footpad inoculation (Dix et al., 1983; Thompson et al., 1986 ) suggest a universal deficit in KOS neuroinvasiveness. Whether HSV-1 KOS enters the nervous system at a high frequency but does not replicate efficiently will be a subject of future investigation. Neuronal entry and spread are determined in part by gE/gI (Dingwell et al., 1995) , but many viral gene products have been described as neurovirulence or pathogenic factors and may have a role in promoting replication in neurons. The viral determinants that contribute to McKrae's in vivo phenotypes are largely unknown. One study comparing wildtype McKrae to a gK mutant suggested a potential role for gK in neuroinvasiveness (David et al., 2008) ; however, a profound reduction in corneal spread observed with this mutant complicated the interpretation. Additional studies comparing a wild-type HSV-1 strain to gB, ICP34,5, or uracil DNA glycosylase in vivo (Bergstrom et al, 1992; Bower et al., 1999; Pyles and Thompson, 1994) , suggest roles for these gene products in neuroinvasion, Sequence analyses of the KOS and McKrae genomes (Macdonald et al. 2012a; Macdonald et al. 2012b; Watson et al., 2012) indicate non-synonymous variations in these genes and many others, some of which are expected to delineate the molecular basis for differences in the pathogenicity of these two HSV-1 strains. 
